HFCAS OpenIR

Browse/Search Results:  1-10 of 195 Help

Selected(0)Clear Items/Page:    Sort:
'Passive' nanoparticles for organ-selective systemic delivery: design, mechanism and perspective 期刊论文
CHEMICAL SOCIETY REVIEWS, 2023
Authors:  Fu, Liyi;  Zhang, Yang;  Farokhzad, Ryan A.;  Mendes, Barbara B.;  Conde, Joao;  Shi, Jinjun
Favorite  |  View/Download:28/0  |  Submit date:2023/11/17
Development of a novel PROTAC using the nucleic acid aptamer as a targeting ligand for tumor selective degradation of nucleolin 期刊论文
MOLECULAR THERAPY-NUCLEIC ACIDS, 2022, 卷号: 30
Authors:  Zhang, Lin;  Li, Ling;  Wang, Xia;  Liu, Huimin;  Zhang, Yibin;  Xie, Tiantian;  Zhang, Hui;  Li, Xiaodong;  Peng, Tianhuan;  Sun, Xing;  Dai, Jing;  Liu, Jing;  Wu, Wencan;  Ye, Mao;  Tan, Weihong
Favorite  |  View/Download:42/0  |  Submit date:2022/12/23
The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review 期刊论文
TRANSLATIONAL CANCER RESEARCH, 2022
Authors:  He, Libin;  Shen, Xiabo;  Liu, Yiyuan;  Gao, Lu;  Wu, Jiayi;  Yu, Chang;  Li, Guangliang;  Wang, Xiaojia;  Shao, Xiying
Favorite  |  View/Download:37/0  |  Submit date:2022/12/23
Advanced human epidermal growth factor receptor 2-positive breast cancer (advanced HER2-positive breast cancer)  apatinib  case report  
Olanzapine for the Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting: A Review to Identify the Best Way to Administer the Drug 期刊论文
CURRENT ONCOLOGY, 2022, 卷号: 29
Authors:  Zhang, Xiao-Ling;  Ying, Jie-Er
Favorite  |  View/Download:37/0  |  Submit date:2022/12/23
olanzapine  CINV  mechanism  dosage  time  routes  
Hypoxia-inducible factor 1-alpha is a driving mechanism linking chronic obstructive pulmonary disease to lung cancer 期刊论文
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12
Authors:  Xu, Yuan-rui;  Wang, An-long;  Li, Ya-qing
Favorite  |  View/Download:40/0  |  Submit date:2022/12/23
chronic obstructive pulmonary disease  lung cancer  non-small cell lung cancer  hypoxia-inducible factor 1-alpha  hypoxia-inducible factor 1  
Darinaparsin (ZIO-101) enhances the sensitivity of small-cell lung cancer to PARP inhibitors 期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
Authors:  Cao, Guo-Zhen;  Ma, Li-Ying;  Zhang, Zong-Hui;  Wang, Xiao-Lin;  Hua, Jing-Han;  Zhang, Jia-Hui;  Lv, Yang;  Zhang, Shao-Bo;  Ou, Jian;  Lin, Wen-Chu
Favorite  |  View/Download:43/0  |  Submit date:2022/12/22
small-cell lung cancer  H3  3  PARP1  PARP inhibitor  darinaparsin  combination treatment  
Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: a retrospective study 期刊论文
BMC PULMONARY MEDICINE, 2022, 卷号: 22
Authors:  Wei, Jingwen;  Xiang, Jing;  Hao, Yue;  Si, Jinfei;  Wang, Wenxian;  Li, Fangyin;  Song, Zhengbo
Favorite  |  View/Download:38/0  |  Submit date:2022/12/22
Anemia  Epidermal growth factor receptor  Epidermal growth factor receptor tyrosine kinase inhibitors  Non-small cell lung cancer  
Pulmonary Epithelial-Myoepithelial Carcinoma 期刊论文
JOURNAL OF ONCOLOGY, 2022, 卷号: 2022
Authors:  Chen, Lingru;  Fan, Ying;  Lu, Hongyang
Favorite  |  View/Download:28/0  |  Submit date:2022/12/23
Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies 期刊论文
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13
Authors:  Wu, Xiaofan;  Yang, Hongjian;  Yu, Xingfei;  Qin, Jiang-Jiang
Favorite  |  View/Download:46/0  |  Submit date:2022/12/22
HER2  breast cancer  targeted therapy  drug resistance  overcoming strategies  
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China 期刊论文
THORACIC CANCER, 2022
Authors:  Xu, Chunwei;  Si, Lu;  Wang, Wenxian;  Li, Ziming;  Song, Zhengbo;  Wang, Qian;  Liu, Aijun;  Yu, Jinpu;  Fang, Wenfeng;  Zhong, Wenzhao;  Wang, Zhijie;  Zhang, Yongchang;  Liu, Jingjing;  Zhang, Shirong;  Cai, Xiuyu;  Liu, Anwen;  Li, Wen;  Zhan, Ping;  Liu, Hongbing;  Lv, Tangfeng;  Miao, Liyun;  Min, Lingfeng;  Chen, Yu;  Yuan, Jingping;  Wang, Feng;  Jiang, Zhansheng;  Lin, Gen;  Pu, Xingxiang;  Lin, Rongbo;  Liu, Weifeng;  Rao, Chuangzhou;  Lv, Dongqing;  Yu, Zongyang;  Lei, Lei;  Li, Xiaoyan;  Tang, Chuanhao;  Zhou, Chengzhi;  Zhang, Junping;  Xue, Junli;  Guo, Hui;  Chu, Qian;  Meng, Rui;  Wu, Jingxun;  Zhang, Rui;  Hu, Xiao;  Zhou, Jin;  Zhu, Zhengfei;  Li, Yongheng;  Qiu, Hong;  Xia, Fan;  Lu, Yuanyuan;  Chen, Xiaofeng;  Ge, Rui;  Dai, Enyong;  Han, Yu;  Pan, Weiwei;  Luo, Jiancheng;  Jia, Hongtao;  Dong, Xiaowei;  Pang, Fei;  Wang, Kai;  Wang, Liping;  Zhu, Youcai;  Xie, Yanru;  Lin, Xinqin;  Cai, Jing;  Wei, Jia;  Lan, Fen;  Feng, Huijing;  Wang, Lin;  Du, Yingying;  Yao, Wang;  Shi, Xuefei;  Niu, Xiaomin;  Yuan, Dongmei;  Yao, Yanwen;  Huang, Jianhui;  Zhang, Yinbin;  Sun, Pingli;  Wang, Hong;  Ye, Mingxiang;  Wang, Dong;  Wang, Zhaofeng;  Wan, Bing;  Lv, Donglai;  Wei, Qing;  Kang, Jin;  Zhang, Jiatao;  Zhang, Chao;  Yu, Genhua;  Ou, Juanjuan;  Shi, Lin;  Li, Zhongwu;  Liu, Zhefeng;  Liu, Jing;  Yang, Nong;  Wu, Lin;  Wang, Huijuan;  Jin, Gu;  Yang, Liu;  Wang, Guansong;  Fang, Meiyu;  Fang, Yong;  Li, Yuan;  Wang, Xiaojia;  Zhang, Yiping;  Ma, Shenglin;  Wang, Biyun;  Zhang, Xiaotian;  Song, Yong;  Lu, Yuanzhi
Favorite  |  View/Download:48/0  |  Submit date:2022/12/22
fusion  precision medicine  solid tumor  targeted therapy  tyrosine receptor kinase